Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 10 Feb 2016 for KERYX BIOPHARMACEUTICALS INC. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
No signal scores available.
Greg Madison: trading record in brief
Greg Madison discloses dealings in Keryx Biopharmaceuticals Inc to SEC (Form 4). In total, 3 filings cover trades dated from 6 January 2016 to 9 February 2016.
Every open-market trade on record is a sale: 2 sales. The amount is not disclosed for 2 filings. Other entries cover 1 share grant.
The latest filing, published on 10 February 2016, reports an open-market sale in Keryx Biopharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Greg Madison
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
1,938 sharesCommon StockSEC:0000899243-16-013036:0
153,750 sharesCommon StockSEC:0000899243-16-012467:0
4,261 sharesCommon StockSEC:0000899243-16-011229:0
3 of 3 declarations
